1

Identity

Laboratorios Normon, S.A.

A28456820

€16.1M

Amount awarded, solo awards 2016–2026

Amount awarded by year
YearAmountDistribution
2026*€1.66M
2025€2.73M
2024€2.41M
+ regional platforms
2023€2.52M
2022€1.47M
2021€3.30M
2020€0.62M
2019€0.88M
2018€0.16M
2017€0.10M
2016€0.23M
*2026: data to 31 October · 60 contracts in 2026 · Since 2024 this also includes data from regional platforms. · Solo awards, excluding JVs · Framework agreements at €0 · €M
845
Contracts (lots)
across 541 tenders
30
Buyers
78%
Single bidder
7
Awards in UTEs
not in the total

In figures

Volume

Between 2016 and 2026 it won 845 contracts worth €16.1M on its own, with 30 buyers. Its 7 joint-venture (UTE) contracts are shown separately.

Price

In 2024–2026 its median discount was 20.5%; the middle half of its discounts between 8.5% and 32.3% (33 comparable awards).

Competition

Since 2024, 47% of its comparable value was won with a discount and against other bidders. It was the only bidder in 78% of its contracts (2016–2026).

Renewals

57 contracts (€2.03M) come up for tender again in the next 24 months.

A UTE is a temporary joint venture: the contract is awarded to the UTE and each partner's share is not published. That is why these contracts are not added to Laboratorios Normon, S.A.'s total, and under «Show UTEs» the amounts are the full value of each contract (100%), not Laboratorios Normon, S.A.'s share.

Data up to 31 October 2026 · updated on 12 November 2026 · Source: official data, national and regional coverage

2

Its discounts

The discount at which it wins contested contracts, year by year.

2024–2026: median 20.5% · middle half between 8.5% and 32.3% · 33 awards

2018–2023: median 17.3% (45 awards) · 2024–2026: median 20.5% (33 awards).

2018–2026: median 17.5% · middle half between 7.2% and 34.6% · 78 awards

Discount on the tender budget, excluding VAT, on awards above the minor-contract threshold · Source: official data, national and regional coverage. Methodology →

Where it wins, and at what discount

In the report · these discounts, one by one

Each dot on the chart is an award. The report lists them all and groups them by buyer and by sector, next to the discounts of other companies with the same buyers.

By sector

Productos farmacéuticos

CPV 336

356 contracts · €6.80M

By buyer · 2024–2026

Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil

Productos farmacéuticos

227 contracts · €2.34M

Servicio Murciano de Salud - Junta de Compras

Productos farmacéuticos

12 contracts · €1.18M

Servicio de Salud - Servicios Centrales

Productos farmacéuticos

2 contracts · €396k

Dirección General de Planificación Económica

Productos farmacéuticos

7 contracts · €275k

Request the report →

Full list: date, buyer, amount, budget, discount, bidders and a link to the official publication.

Distribution of its discounts
How far winning bids are below the published contract value — its contested awards, the same ones the chart shows.
Median discount: 20.5% below the published contract value · 33 awards (2024–2026).
Discount
Awards
0 %awarded at budget
2
0–5 %
5
5–15 %
7
15–30 %
8
30 %+
11

24 awards at the tender price, left out of the discounts.

3

How it wins

Whether it wins with or without competition.

Competition and pricing

47% of the comparable value since 2024 (€1.27M of €2.72M) was won with a discount and against other bidders. €856k (32%) was awarded with a discount and without other bidders.

With a discount
32%
single bidder · 30 · €856k
47%
multiple bidders · 31 · €1.27M
At the tender price
19%
single bidder · 9 · €521k
3%
multiple bidders · 2 · €69.3k

Comparable: 72 awards with a published budget and bidder count (€2.72M of €6.80M awarded since 2024). Percentages of value; the figure next to «bidders» is the number of awards. Source: official data, national and regional coverage.

Award procedure

Between 2016 and 2026, 61.8% of the value was awarded through open procedure (51.8% of contracts); followed by Based on a framework agreement (30.6%) and Negotiated without publicity (4.1%).

Open · 61.8%
Based on a framework agreement · 30.6%
Open
Simplified open
Restricted
Based on a framework agreement
Negotiated without publicity
Other
4

Upcoming tenders and main buyers

When its contracts come back and who it sells to.

When its contracts come back

In the next 24 months 57 of its contracts come up for tender again, worth €2.03M.

Expected endBuyerValue
2026Servicio de Salud - Servicios Centrales€160k
2026OSAKIDETZA - Servicio Vasco de Salud -Director General€79.2k
2027OSAKIDETZA - Servicio Vasco de Salud -Director General€24.0k
2027Gerencia Asistencial de Atención Primaria€20.5k
2027Gerencia Sector Sanitario de Zaragoza 2€2.64k

and 52 more in the next 24 months · the report includes them all

Expected end year from the published duration (no extensions). The report includes the month and the discount it won each one at.

Who they sell to
BuyerContractsValue, €Period
Gerencia de Servicio Sanitarios de Fuerteventura4967.4 M2019–2026
Servicio Murciano de Salud - Junta de Compras212.3 M2022–2026
OSAKIDETZA - Servicio Vasco de Salud -Director General271.3 M2024–2026
Servicio de Salud - Servicios Centrales10952 k2021–2026
Gerencia de Atención Integrada de Talavera de la Reina83567 k2018–2025

and 25 more buyers

Sector activity
Top CPV codes — the EU classification system that identifies the type of works, services or supplies covered by each contract.

Between 2016 and 2026, 100.0% of the value it won on its own is in Medical & pharmaceuticals (CPV 33, 843 contracts).

Medical & pharmaceuticals
100.0%843 contracts
5

Recent awards

The evidence behind every insight in the report.

Latest 5 completed contracts (of 356)
Contracts whose expected completion date has passed.
DateContractBuyerBiddersValue
18/06/2026Medicamentos con destino a los Centros de Atención Primaria del Servicio Madrileño de SaludGerencia Asistencial de Atención Primaria1€8.04k
04/11/2025Suministro de Omeprazol (DOE), Temozolomida (DOE), Teicoplanina (DOE) y Folinato cálcico (DOE)OSAKIDETZA - Servicio Vasco de Salud -Director General2€79.2k
11/09/2025cbam_laboratorioa normon, s.a. -acuerdo marco con una unica empresa para el suministro, de tracto s…Servicio Andaluz de Salud1€16.0k
11/08/2025Suministro de Sildenafilo (DOE), Ibuprofeno (DOE), Fenilefrina (DOE) Y Caspofungina (DOE)OSAKIDETZA - Servicio Vasco de Salud -Director General1€7.00k
08/08/2025Suministro lote 195 del acuerdo marco para el suministro de medicamentos de uso humano tipo I, incl…Dirección Gerencia del Complejo Hospitalario Universitario de Canarias1€4.77k
Full report on Laboratorios Normon, S.A.
Includes: its discount by buyer and sector · winning discounts by buyer and year · how it wins with each buyer · contract renewal calendar. The complete register of its awards in the last three full calendar years and the current year to date, in Excel.
€50 + VAT · VAT is calculated at payment according to your country. You will receive it in PDF and Excel by email within one working day. Every report is reviewed by a person before it is sent to you.
Order the report